Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis
- Resource Type
- Article
- Source
- In
Hematology/Oncology and Stem Cell Therapy December 2020 13(4):232-237 - Subject
- Language
- ISSN
- 1658-3876